Skip to Main Content

Paper Details

Immunogenicity and Reactogenicity Following 2- and 3-Dose SARS-CoV-2 Vaccination in Persons With HIV.
J Acquir Immune Defic Syndr
0
2023
Author NameAffiliation
Kelly A GeboJohns Hopkins University School of Medicine
Kelly A GeboJohns Hopkins School of Public Health
  • 1 - 2

Datasets

Release 1.2